undamentalytics Newsletter

Kramvis Andreas: insider trades

Chief executive, Officer at Honeywell Technologies. No open-market purchases and 18 sales not made under a pre-set plan, reported from March 3, 2010 to July 29, 2016.

What happened after Kramvis Andreas’s sales?

After their sales, the shares moved +7.2% against the index over 12 months on average (a negative figure means selling was the right call); 11% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Kramvis Andreas: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 18 +1.6% +0.8% 39% 7 1.61 0.16 No reliable evidence
Sales, 12 months after the report 18 +7.2% +5.8% 11% 7 3.49 0.013 Some evidence: seller wrong
Sales, 12 months after the trade 18 +6.7% +4.8% 17% 7 2.44 0.050 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Honeywell Technologies HON Vice Chairman018March 3, 2010July 29, 2016

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
July 29, 2016July 28, 2016 HON Sale $212,380 −2.7%+5.1%+5.2%
May 23, 2016May 18, 2016 HON Sale $2,099,880 −3.1%+0.5%+0.9%
April 28, 2016April 27, 2016 HON Sale $5,915,173 −3.4%−0.4%−0.8%
November 19, 2015November 18, 2015 HON Sale $175,996 +5.5%+1.7%+4.5%
May 19, 2015May 18, 2015 HON Sale $8,740,346 +1.0%+10.1%+11.1%
May 15, 2014May 12, 2014 HON Sale $6,734,122 −0.7%+3.9%−2.2%
August 12, 2013August 9, 2013 HON Sale $3,311,610 −0.1%−2.2%−2.7%
April 25, 2013April 24, 2013 HON Sale $9,170,871 +5.3%+7.2%+6.3%
November 8, 2012November 6, 2012 HON Sale $989,720 +5.8%+15.9%+13.0%
November 5, 2012November 1, 2012 HON Sale $729,532 +5.2%+13.0%+15.9%
August 20, 2012August 17, 2012 HON Sale $697,713 +4.3%+20.7%+20.2%
March 2, 2012March 1, 2012 HON Sale $470,608 −3.5%+9.6%+6.1%
March 1, 2012February 28, 2012 HON Sale $155,376 −2.9%+7.4%+7.3%
December 21, 2011December 20, 2011 HON Sale $43,360 +0.2%+4.2%+3.5%
November 17, 2011November 15, 2011 HON Sale $49,635 +0.6%+1.1%+1.1%
October 28, 2011October 27, 2011 HON Sale $64,992 +7.0%+6.4%+4.5%
December 22, 2010December 20, 2010 HON Sale $1,321,488 +3.0%+3.1%+2.8%
March 3, 2010March 2, 2010 HON Sale $12,914 +7.1%+22.0%+23.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Kramvis Andreas traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.